Conditions: Hepatocellular Carcinoma (HCC)
Interventions: Procedure: Transarterial chemoembolization (TACE); Radiation: Stereotactic Body Radiation Therapy (SBRT); Radiation: SIRT Yttrium-90; Drug: Atezolizumab & Bevacizumab
Sponsors: Tuen Mun Hospital; Queen Mary Hospital, Hong Kong; The University of Hong Kong; The University of Hong Kong-Shenzhen Hospital
Recruiting Conditions: Hepatocellular Carcinoma (HCC)
Interventions: Procedure: Transarterial chemoembolization (TACE); Radiation: Stereotactic Body Radiation Therapy (SBRT); Radiation: SIRT Yttrium-90; Drug: Atezolizumab & Bevacizumab
Sponsors: Tuen Mun Hospital; Queen Mary Hospital, Hong Kong; The University of Hong Kong; The University of Hong Kong-Shenzhen Hospital
Recruiting
